[1]李岗峰,李刘文,刘　璐.慢性心力衰竭患者血清内源性Apela，NT-proBNP及CysC水平与并发肾功能不全的相关性分析[J].现代检验医学杂志,2022,37(03):167-171.[doi:10.3969/j.issn.1671-7414.2022.03.035]
　LI Gang-feng,LI Liu-wen,LIU Lu.Correlation Analysis of Serum Endogenous Apela, NT-proBNP, Cys C Levels and Renal Insufficiency in Patients with Chronic Heart Failure[J].Journal of Modern Laboratory Medicine,2022,37(03):167-171.[doi:10.3969/j.issn.1671-7414.2022.03.035]
点击复制

慢性心力衰竭患者血清内源性Apela，NT-proBNP及CysC水平与并发肾功能不全的相关性分析()
分享到：

《现代检验医学杂志》[ISSN:/CN:]

卷:
第37卷
期数:
2022年03期
页码:
167-171
栏目:
检验与临床
出版日期:
2022-05-15

文章信息/Info

Title:
Correlation Analysis of Serum Endogenous Apela, NT-proBNP, Cys C Levels and Renal Insufficiency in Patients with Chronic Heart Failure
文章编号:
1671-7414（2022）03-167-05
作者:
李岗峰; 李刘文; 刘　璐
（榆林市第二医院急诊科，陕西榆林 719000）
Author(s):
LI Gang-feng; LI Liu-wen; LIU Lu
（Department of Emergency,the Second Hospital of Yulin City, Shaanxi Yulin 719000, China）
关键词:
慢性心力衰竭; 肾功能不全; 氨基末端脑钠肽前体; 胱抑素C; 内源性Apela
分类号:
R541.6；R446.11
DOI:
10.3969/j.issn.1671-7414.2022.03.035
文献标志码:
A
摘要:
目的　探讨血清内源性 Apela，氨基末端脑钠肽前体（ N-terminal pro-B type natriuretic peptide, NT-proBNP）及胱抑素 C（cystatin C, Cys C）在慢性心力衰竭（chronic heart failure, CHF）中的表达及与并发肾功能不全的相关性分析。方法　选择 2017年 1月～ 2019年 12月于榆林市第二医院就诊的慢性心力衰竭患者 200例作为研究对象，并根据患者肾功能分为肾功能正常组（ n=92）和肾功能不全组（ n=108），采用全自动生化分析仪检测患者血清肌酐（ creatinine， Cr）和尿素氮（ blood urea nitrogen, BUN）含量，采用酶联免疫吸附法试剂盒检测患者血清中 NT-proBNP,Apela及 Cys C含量，并根据 Cr水平计算肾小球滤过率（ eGFR），比较两组间差异，并采用 Logistic回归分析筛选慢性心力衰竭并发肾功能不全的危险因素，绘制 ROC曲线判断 NT-proBNP,Apela和 Cys C对慢性心力衰竭并发肾功能不全的预测价值。结果　肾功能正常组左心室射血分数（ left ventricular ejection fraction，LVEF）明显高于肾功能不全组（ 48.95%±5.56 % vs 44.16%±7.18%），心功能分级明显优于肾功能不全组 ,差异均有统计学意义（ t=7.360，P＜ 0.001；χ2=9.067， P=0.026）。两组患者性别、年龄、病程、 BMI和基础心脏病情况差异均无统计学意义（均 P＞ 0.05）。肾功能不全组 BUN（8.23±2.78mmol/L），Cr（269.78±21.90μmol/L），NT-proBNP（6 064.12±163.81pg/ml），Cys C（1.68±0.03mg/ L）和 Apela（1.29±0.42 ng/L）大于肾功能正常组 (3.16±1.29 mmol/L, 73.90±13.46μmol/L, 3 157.21±180.38pg/ml, 0.74± 0.05 mg/L, 0.76±0.47ng/L)，eGFR（42.38±9.31 ml/min/1.73m2）小于肾功能正常组（110.92±16.68ml/min/1.73m2）, 差异均有统计学意义（ t=23.948，109.414, 168.840, 223.092, 11.908，49.550，均 P＜ 0.001）。Logistic回归分析结果显示： LVEF，心功能分级、 BUN, Cr, NT-proBNP, eGFR, Cys C以及 Apela均是慢性心力衰竭并发肾功能不全的危险因素（均 OR＞ 1，P＜ 0.05）。NT-proBNP,Apela和 Cys C诊断慢性心力衰竭并发肾功能不全 AUC分别为 0.605，0.708，0.626，特异度分别为 0.642，0.658，0.694，敏感度分别为 0.618，0.731，0.714;三者联合诊断慢性心力衰竭并发肾功能不全的 AUC为 0.747，特异度和敏感度分别为 0.762，0.737。结论　NT-proBNP, Cys C和 Apela是慢性心力衰竭并发肾功能不全的危险因素，且三者联合诊断价值较高，对于临床诊断和治疗有一定的参考价值。
Abstract:
Objective　To investigate the expression of serum endogenous Apela，N-terminal pro-B type natriuretic peptide （NT-proBNP）and cystatin C（Cys C）in chronic heart failure（CHF） and the correlation between them and renal insufficiency. Methods　Two hundred patients with CHF who were treated at the Second Hospital of Yulin City from January 2017 to December 2019 were selected as the research objects.They were divided into normal renal function group (n=92) and incomplete renal function group (n=108 ). Automatic biochemical analyzer was used to detect the content of creatinine (Cr) and urea nitrogen (BUN) in patients, and the enzyme-linked immunosorbent assay kit was used to detect the levels of NT-proBNP， Apela and Cys C in the patient’s serum. Glomerular filtration rate (eGFR) was calculated based on Cr level, and the differences between the two groups were compared. Logistic regression analysis was used to screen the risk factors of CHF with renal insufficiency, and ROC curve was drawn to judge the predictive value of NT-proBNP, Apela and Cys C in CHF with renal insufficiency. Results　Left ventricular ejection fraction（LVEF） of normal renal function group was significantly higher than that of renal insufficiency group（48.95%±5.56 % vs 44.16%±7.18%），and heart function grade was significantly better than that of renal insufficiency group，the difference was statistically significant （t=7.360，P ＜ 0.001；χ2=9.067，P=0.026）. There was no significant difference in gender, age, course of disease, BMI and basic heart disease between the two groups (all P ＞ 0.05). BUN（8.23±2.78mmol/L），Cr（269.78±21.90 μmol/L），NT-proBNP（6 064.12±163.81pg/ml），Cys C （1.68±0.03mg/L）and Apela（1.29±0.42 ng/L）in renal insufficiency group were higher than those in normal renal function group(3.16±1.29 mmol/L,73.90±13.46μmol/L, 3 157.21±180.38pg/ml,0.74±0.05 mg/L,0.76±0.47ng/L), and eGFR （42.38±9.31 ml/min/1.73m2）was lower than those in normal renal function group（110.92±16.68ml/min/1.73m2），the differences were statistically significant（t=23.948，109.414, 168.840, 223.092, 11.908, 49.550，all P ＜ 0.001）. Logistic regression analysis showed that LVEF, heart function grade, BUN, Cr, NT-proBNP, eGFR, Cys C and Apela were the risk factors of CHF with renal insufficiency(all OR >1，P < 0.05). The AUC of NT-proBNP,Apela and Cys C in the diagnosis of CHF with renal insufficiency were 0.605, 0.708 and 0.626, respectively. The specificity was 0.642, 0.658 and 0.694, respectively. The sensitivity was 0.618, 0.731 and 0.714, respectively. The AUC of the combined diagnosis of CHF with renal insufficiency was 0.747, and the specificity and sensitivity were 0.762 and 0.737, respectively. Conclusion　NT-proBNP, Cys C and Apela are the risk factors of CHF with renal insufficiency, and the combined diagnosis of the three factors is of high value, which has a certain reference value for clinical diagnosis and treatment.

参考文献/References:

[1] YU DORIS S F, LI POLLY W C, YUE SUNNY C S, et al. The effects and cost-effectiveness of an empowerment-based self-care programme in patients with chronic heart failure: A study protocol[J]. Journal of Advanced Nursing, 2019, 75(12): 3740-3748.
[2] 易福凌, 陈伟芝, 王禺．慢性心力衰竭患者血清 Mb,cTnI,IL-8 和hs-CRP 水平表达与心功能分级的 相关性研究[J]. 现代检验医学杂志, 2021, 36(3): 58- 61, 67. YI Fuling, CHEN Weizhi, WANG Yu. Correlation between the expression of serum MB, cTnI, IL-8, hs- CRP and cardiac function in patients with chronic heart failure[J]. Journal of Modern Laboratory Medicine, 2021, 36(3): 58-61, 67.
[3] COMO J M. Health literacy and health status in people with chronic heart failure[J]. Clinical Nurse Specialist, 2018, 32(1): 29-42.
[4] ABAZID R M, KHALAF H H, SAKR H I, et al. Effects of Ramadan fasting on the symptoms of chronic heart failure[J]. Saudi Medical Journal, 2018, 39(4): 395-400.
[5] KANE P M, MURTAGH F E M, RYAN K R, et al. Strategies to address the shortcomings of commonly used advanced chronic heart failure descriptors to improve recruitment in palliative care research: A parallel mixed-methods feasibility study[J]. Palliative Medicine, 2018, 32(2): 517-524.
[6] FREYER L, HSU C W, NOWOTSCHIN S, et al. Loss of Apela peptide in mice causes low penetrance embryonic lethality and defects in early mesodermal derivatives[J]. Cell Reports, 2017, 20(9): 2116-2130.
[7] 张兴宗, 林云, 邹映东, 等．4 项肾小球滤过功能检 测指标在肾功能不全中的临床应用分析[J]. 国际检 验医学杂志, 2016, 37（(10):1395-1396. ZHANG Xingzong, LIN Yun, ZOU Yingdong, et al. Analysis of the clinical application of 4 indexes of glomerular filtration function in renal insufficiency[J]. International Journal of Laboratory Medicine, 2016, 37(10): 1395-1396.
[8] 中华医学会心血管病学分会心力衰竭学组, 中国医 师协会心力衰竭专业委员会, 中华心血管病杂志编 辑委员会. 中国心力衰竭诊断和治疗指南2018[J]. 中华心血管病杂志, 2018, 46(10):760-789. Heart Failure Group of Chinese Society of Cardiology, Chinese Heart Failure Association of Chinese Medical Doctor Association, Editorial Board of Chinese Journal of Cardiology. Chinese guidelines for the diagnosis and trentment of heart failure 2018 [J]. Chinese Journal of Cardiology, 2018, 46(10): 760-789.
[9] 中华医学会心血管病学分会, 中华心血管病杂志编 辑委员会．慢性心力衰竭诊断治疗指南[J]. 中华心 血管病杂志, 2007, 35(12):1076-1095. Chinese Society of Cardiology of Chinese Medical Association, Editorial Board of Chinese Journal of Cardiology. Guidelines for the diagnosis and management of chronic heart failure [J]. Chinese Journal of Cardiology, 2007, 35(12): 1076-1095.
[10] 刘永久, 查云飞, 李军, 等. 肾脏IVIM-DWI 在慢性 肾脏病肾功能评估中的应用初步研究[J]. 临床放射 学杂志, 2017, 36(8):1145-1149. LIU Yongjiu, ZHA Yunfei, LI Jun, et al. The preliminary application study of IVIM-DWI imaging for evaluating renal function in chronic kidney disease[J]. Journal of Clinical Radiology, 2017, 36(8): 1145-1149.
[11] 崔贞, 刘文．慢性心力衰竭患者呋塞米治疗对血 清NT-proBNP 水平的影响[J]. 现代检验医学杂志, 2019, 34(3):144-147. CUI Zhen, LIU Wen. Effects of furosemide in patients with chronic heart failure on serum NT-proBNP [J]. Journal of Modern Laboratory Medicine, 2019, 34(3): 144-147.
[12] HALADE G V, KAIN V, SERHAN C N. Immune responsive resolvin D1 programs myocardial infarctioninduced cardiorenal syndrome in heart failure[J]. FASEB Journal, 2018, 32(7): 3717-3729.
[13] THIND G S, LOEHRKE M, WILT J L. Acute cardiorenal syndrome: Mechanisms and clinical implications[J]. Cleveland Clinic Journal of Medicine, 2018, 85(3): 231-239.
[14] 陈国栋, 叶健烽, 黄志超, 等. 慢性肾功能不全对糖 尿病合并冠心病患者临床表现及预后的影响[J]. 中 国老年学杂志, 2017, 37(15):3725-3727. CHEN Guodong, YE Jianfeng, HUANG Zhichao, et al. Effect of chronic renal insufficiency on the clinical performances and prognosis of patients with diabetes combiend with cornary heart disease [J]. Chinese Journal of Gerontology, 2017, 37(15): 3725-3727.
[15] KAZORY A, COSTANZO M R. The dynamic relationship between serum chloride and cardiorenal syndrome[ J]. Reviews in Cardiovascular Medicine, 2020, 21(1): 25-29.
[16] CHAHAL R S, CHUKWU C A, KALRA P R, et al. Heart failure and acute renal dysfunction in the cardiorenal syndrome the burden of heart failure[J]. Clinical Medicine, 2020, 20(2): 146-150.
[17] 陈蓉, 陆爱民, 张晓春. 血清Cys C 及NHE1mRNA 水平检测在心力衰竭诊断中的临床应用[J]. 标记免 疫分析与临床, 2019, 26(2):281-284, 298. CHEN Rong, LU Aimin, ZHANG Xiaochun. Clinical application of serum CysC level and NHE1 mRNA level in the diagnosis of heart failure [J]. Labeled Immunoassays and Clinical Medicine, 2019, 26(2): 281-284,298.
[18] 潘扬, 王治, 黄进．血清内源性Apela, 胱抑素C 水 平在慢性心力衰竭肾功能不全评估中应用价值[J]． 中国心血管病研究, 2019, 17(6): 522-525. PAN Yang, WANG Zhi, HUANG Jin. The value of serum levels of Apela and Cystatin C in evaluation of renal insufficiency in patients with heart failure [J]. Chinese Journal of Cardiovascular Research, 2019, 17(6): 522-525.
[19] 邸平, 孙京花, 张帆．血清学指标检测在慢性肾功 能不全疾病早期诊断和临床分期中的应用价值[J]． 中国医学装备, 2019, 16（6）：76-79． DI Ping, SUN Jinghua, ZHANG Fan. The application value of serological indicator detection in early diagnosis and clinical staging of chronic renal insufficiency [J]. China Medical Equipment, 2019, 21(6): 76-79.

相似文献/References:

[1]李德璇,王玉明,杨红玲,等.亲环素A与慢性心力衰竭相关性的研究[J].现代检验医学杂志,2015,30(01):31.[doi:10.3969/j.issn.1671-7414.2015.01.009]
　LI De-xuan,WANG Yu-ming,YANG Hong-ling,et al.Study on the Relationship between Cyclophilin A and Chronic HeartFailure[J].Journal of Modern Laboratory Medicine,2015,30(03):31.[doi:10.3969/j.issn.1671-7414.2015.01.009]
[2]崔 贞,刘 文.慢性心力衰竭患者呋塞米治疗对血清NT-proBNP水平的影响[J].现代检验医学杂志,2019,34(03):144.[doi:10.3969/j.issn.1671-7414.2019.03.037]
　CUI Zhen,LIU Wen.Effects of Furosemide in Patientswith Chronic Heart Failure on Serum NT-proBNP[J].Journal of Modern Laboratory Medicine,2019,34(03):144.[doi:10.3969/j.issn.1671-7414.2019.03.037]
[3]余久如a,卢锦莲b,廖建红a,等.高效液相色谱法检测慢性肾功能不全患者羟苯磺酸钙稳态血药浓度与eGFR及肌酐干扰值相关性分析[J].现代检验医学杂志,2019,34(04):62.[doi:10.3969/j.issn.1671-7414.2019.04.015]
　YU Jiu-rua,LU Jin-lianb,LIAO Jian-honga,et al.Determination of the Steady-State Plasma Concentration of Calcium Dobesilate in Patients with Chronic Renal Insufficiency by HPLC and Its Correlation with eGFR and Creatinine Interference[J].Journal of Modern Laboratory Medicine,2019,34(03):62.[doi:10.3969/j.issn.1671-7414.2019.04.015]
[4]易福凌,陈伟芝,王　禺.慢性心力衰竭患者血清 Mb，cTnI，IL-8 和 hs-CRP 水平表达与心功能分级的相关性研究[J].现代检验医学杂志,2021,36(03):58.[doi:10.3969/j.issn.1671-7414.2021.03.013]
　YI Fu-ling,CHEN Wei-zhi,WANG Yu.Correlation between the Expression of Serum MB, cTnI, IL-8, hs-CRP andCardiac Function in Patients with Chronic Heart Failure[J].Journal of Modern Laboratory Medicine,2021,36(03):58.[doi:10.3969/j.issn.1671-7414.2021.03.013]
[5]王　麟,陈惠新,李小燕.慢性心力衰竭患者血清TRPC1,sFRP5和NT-proBNP水平与心功能及疾病严重程度的临床研究[J].现代检验医学杂志,2021,36(06):6.[doi:10.3969/j.issn.1671-7414.2021.06.002]
　WANG Lin,CHEN Hui-xin,LI Xiao-yan.Study on the Relationship between Serum TRPC1, sFRP5 and NT-proBNP Levels and Cardiac Function and Disease Severity in Predicting with Chronic Heart Failure[J].Journal of Modern Laboratory Medicine,2021,36(03):6.[doi:10.3969/j.issn.1671-7414.2021.06.002]
[6]张卫东,乔明刚.老年心衰并发心律失常患者血清Ang-2，CysC水平及hs-CRP/PAB比值对临床预后评估的价值研究[J].现代检验医学杂志,2021,36(06):128.[doi:10.3969/j.issn.1671-7414.2021.06.027]
　ZHANG Wei-dong,QIAO Ming-gang.Value of Serum Ang-2, Cys C and Hs-CRP/PAB Ratio in the Evaluation of Clinical Prognosis in Elderly Patients with Heart Failure Complicated by Arrhythmia[J].Journal of Modern Laboratory Medicine,2021,36(03):128.[doi:10.3969/j.issn.1671-7414.2021.06.027]
[7]王新庄,孟建涛.慢性心力衰竭患者血清 lncRNA MALAT1的表达水平及其临床意义[J].现代检验医学杂志,2022,37(01):141.[doi:10.3969/j.issn.1671-7414.2022.01.028]
　WANG Xin-zhuang,MENG Jian-tao.Expression of lncRNA MALAT1 in Peripheral Blood of Patients with Chronic Heart Failure and Its Clinical Significance[J].Journal of Modern Laboratory Medicine,2022,37(03):141.[doi:10.3969/j.issn.1671-7414.2022.01.028]
[8]陈　伟,侯湘岭.老年慢性心力衰竭患者血清人类母系表达基因3的水平与预后的相关性研究[J].现代检验医学杂志,2022,37(03):26.[doi:10.3969/j.issn.1671-7414.2022.03.006]
　CHEN Wei,HOU Xiang-ling.Study on the Correlation between Serum Human Maternally Expressed Gene 3 Levels and Prognosis in Elderly Patients with Chronic Heart Failure[J].Journal of Modern Laboratory Medicine,2022,37(03):26.[doi:10.3969/j.issn.1671-7414.2022.03.006]
[9]杨 婷a,赵茜茜,褚 杰a,等.慢性心力衰竭患者血清MCP-3，NRG-1β 和CF6 水平表达与疾病严重程度的相关性研究[J].现代检验医学杂志,2022,37(05):139.[doi:10.3969/j.issn.1671-7414.2022.05.027]
　YANG Tinga,ZHAO Qian-qian,CHU Jiea,et al.Study on the Correlation between the Expression of Serum MCP-3, NRG-1β and CF6 Levels in Patients with Chronic Heart Failure and the Severity of the Disease[J].Journal of Modern Laboratory Medicine,2022,37(03):139.[doi:10.3969/j.issn.1671-7414.2022.05.027]
[10]徐锦华a,王慧娟,励 国a,等.老年慢性心力衰竭患者血清SCD-1 和sVEGFR-2 表达水平及其与预后的评估价值研究[J].现代检验医学杂志,2023,38(04):191.[doi:10.3969/j.issn.1671-7414.2023.04.035]
　XU Jinhuaa,WANG Huijuan,LI Guoa,et al.Study on the Expression Level of Serum SCD-1 and sVEGFR-2 in Elderly Patients with Chronic Heart Failure and Its Prognostic Value[J].Journal of Modern Laboratory Medicine,2023,38(03):191.[doi:10.3969/j.issn.1671-7414.2023.04.035]

备注/Memo

备注/Memo:
作者简介：李岗峰（1987-），男，本科，主治医师，研究方向：心内科疾病，E-mail：lgf20681@163.com。
通讯作者：李刘文（1986-），男，本科，主治医师，研究方向：内科疾病，E-mail：liyi0912A@163.com。
更新日期/Last Update: 1900-01-01